David T. Scadden

Biography

Prof. David T. Scadden M.D. Co-Founded the Harvard Stem Cell Institute. Prof. Scadden is the Gerald and Darlene Jordan Professor of Medicine at Harvard University. Prof. Scadden chairs the Department of Stem Cell and Regenerative Biology Department at Harvard University, the first department to span faculties in Harvard’s history. He is a hematologist/oncologist and directs the Center for Regenerative Medicine at the Massachusetts General Hospital and previously chaired the Hematologic Malignancies program in the MGH Cancer Center. He has been an Independent Director at Agios Pharmaceuticals, Inc. since May 31, 2017. Prof. Scadden serves as a Member of Scientific Advisory Board and Director of Magenta Therapeutics, Inc. Prof. Scadden serves as a Member of Scientific Advisory Board at Bone Therapeutics SA. Prof. Scadden served as Member of Scientific Advisory Board at Cordlife Group Limited. He is an expert on the medical applications of stem cell biology with a particular emphasis on their use in the settings of cancer and AIDS. He has published over 300 scientific papers and book chapters and his laboratory has made fundamental contributions in how the stem cell niche regulates stem cell function and in normal and disease-corrupted hematopoiesis. He is a Member of the Institute of Medicine of the National Academies of Science, the American Academy of Arts and Sciences, the Board of External Experts for the National Heart, Lung and Blood Institute. He served as Member of the National Cancer Institute's Board of Scientific Counselors. He has served or serves on the Board of Scientific Counselors for the National Cancer Institute, the Board of External Experts for the National Heart, Lung and Blood Institute, Board of Directors of the International Society for Stem Cell Research (ISSCR) and is an Associate Member of the Broad Institute of Harvard and MIT. He serves on multiple editorial boards and scientific advisory boards and is a scientific founder of Fate Therapeutics. He is the recipient of numerous honors including membership in the National Academy of Medicine, the American Academy of Arts and Sciences and awards from the Doris Duke Charitable Trust, the Ellison Medical Foundation, the Burroughs Welcome Fund and the Leukemia and Lymphoma Society. He is the recipient of multiple honorary degrees.

Research Interest

Stem Cell Research